News | August 04, 2022
Sandu Pharmaceuticals launches Sandu Kumarvin
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The combined company will be able to better serve both our global and regional customers with local production
.jpg)
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
Both manufacturing facilities are based out of Benguluru, India
Subscribe To Our Newsletter & Stay Updated
